Intuitive Surgical Inc. (NASDAQ:ISRG)‘s stock had its “outperform” rating reaffirmed by Leerink Swann in a research report issued to clients and investors on Monday. They presently have a $780.00 price objective on the stock. Leerink Swann’s price objective indicates a potential upside of 11.61% from the company’s previous close.

Several other research analysts have also commented on the company. Zacks Investment Research upgraded Intuitive Surgical from a “hold” rating to a “buy” rating and set a $753.00 target price for the company in a research report on Wednesday, September 14th. Raymond James Financial Inc. assumed coverage on Intuitive Surgical in a research report on Friday, August 26th. They issued an “outperform” rating for the company. Northland Securities lowered Intuitive Surgical from a “market perform” rating to an “under perform” rating and set a $600.00 price objective for the company. in a research report on Thursday, July 21st. Evercore ISI restated a “buy” rating and set a $775.00 price objective (up previously from $750.00) on shares of Intuitive Surgical in a research report on Wednesday, July 20th. Finally, Citigroup Inc. boosted their price objective on Intuitive Surgical from $723.00 to $779.00 and gave the company a “buy” rating in a research report on Wednesday, July 20th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $701.42.

Intuitive Surgical (NASDAQ:ISRG) opened at 698.87 on Monday. Intuitive Surgical has a 52-week low of $447.00 and a 52-week high of $720.01. The stock has a market cap of $26.90 billion, a PE ratio of 39.66 and a beta of 0.73. The firm has a 50-day moving average price of $688.48 and a 200 day moving average price of $648.02.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, July 19th. The company reported $5.62 EPS for the quarter, topping the consensus estimate of $4.97 by $0.65. The company earned $670 million during the quarter, compared to analyst estimates of $640.69 million. Intuitive Surgical had a return on equity of 15.25% and a net margin of 26.80%. During the same quarter last year, the firm earned $4.57 EPS. Equities analysts anticipate that Intuitive Surgical will post $21.30 earnings per share for the current year.

In other news, CFO Marshall Mohr sold 5,000 shares of Intuitive Surgical stock in a transaction on Wednesday, July 27th. The stock was sold at an average price of $684.09, for a total transaction of $3,420,450.00. Following the transaction, the chief financial officer now owns 6,725 shares in the company, valued at $4,600,505.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Mark J. Meltzer sold 3,000 shares of Intuitive Surgical stock in a transaction on Monday, August 22nd. The shares were sold at an average price of $688.33, for a total value of $2,064,990.00. Following the transaction, the senior vice president now owns 2,331 shares in the company, valued at approximately $1,604,497.23. The disclosure for this sale can be found here. 3.10% of the stock is owned by corporate insiders.

Several hedge funds and other institutional investors have recently modified their holdings of ISRG. Global X Management Co. LLC acquired a new position in shares of Intuitive Surgical during the second quarter worth $118,000. Acrospire Investment Management LLC acquired a new position in shares of Intuitive Surgical during the first quarter worth $120,000. Bartlett & Co. LLC increased its position in shares of Intuitive Surgical by 7.3% in the second quarter. Bartlett & Co. LLC now owns 220 shares of the company’s stock worth $146,000 after buying an additional 15 shares in the last quarter. IFP Advisors Inc increased its position in shares of Intuitive Surgical by 3.3% in the first quarter. IFP Advisors Inc now owns 284 shares of the company’s stock worth $171,000 after buying an additional 9 shares in the last quarter. Finally, Glenmede Trust Co. NA increased its position in shares of Intuitive Surgical by 3.0% in the second quarter. Glenmede Trust Co. NA now owns 275 shares of the company’s stock worth $181,000 after buying an additional 8 shares in the last quarter. Institutional investors and hedge funds own 91.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

5 Day Chart for NASDAQ:ISRG

Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.